Authors

  • Феруза Абдулхамитовна Ризаева
  • Сапура Захидовна Ибрагимова
  • Дилфуза Сабуровна Маткаримова

References

Бабаханова Н.Н., Ибрагимова С.З., Маткаримова Д.С., Бобоев К.Т. Опыт применение блинатумомаба при остром лимфобластном лейкозе у детей (клинический случай). – Вестник гематологии, 2023, С.29-31.

Маякова С.А., Немировченко В.С., Попа А.В. Клинические рекомендации по диагностике и лечению детей, больных острыми лейкозами // Общероссийский союз общественных объединений ассоциация онкологов России, Москва, 2014. –9 с.

Aschenbrenner D. S. New Approved Use for Blinatumomab //AJN The American Journal of Nursing. – 2018. – Т. 118. – №. 8. – С. 26-27.

Buie L. W. et al. Blinatumomab: a first-in-class bispecific T-cell engager for precursor B-cell acute lymphoblastic leukemia //Annals of pharma-cotherapy. – 2015. – Т. 49. – №. 9. – С. 1057-1067.

Friberg G., Reese D. Blinatumomab (Blin-cyto): lessons learned from the bispecific t-cell en-gager (BiTE) in acute lymphocytic leukemia (ALL) //Annals of Oncology. – 2017. – Т. 28. – №. 8. – С. 2009-2012.

Gökbuget N. et al. Long-term outcomes after blinatumomab treatment: follow-up of a phase 2 study in patients (Pts) with minimal residual disease (MRD) positive B-cell precursor acute lymphoblastic leukemia (ALL) //Blood. – 2015. – Т. 126. – №. 23. – С. 680.

Jen E. Y. et al. FDA approval: blinatumomab for patients with B-cell precursor acute lympho¬blastic leukemia in morphologic remission with minimal residual disease //Clinical Cancer Research. – 2019. – Т. 25. – №. 2. – С. 473-477.

Rathod K., Rani S., Satish S. Efficacy of CRISPR-Cas9 CAR T-Cell Therapy vs. Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia //Undergraduate Research in Natural and Clinical Science and Technology Journal.–2021.–Т. 5. – С. 1-7.

Rizzieri D. A. et al. Trial in Progress: A Phase 2 Single Arm, Multicenter Trial to Evaluate the Efficacy of the BiTE® Antibody Blinatumomab (Blin-cyto) and Vincristine Sulfate Liposomal Injection (Marqibo) in Adult Subjects with Relapsed / Refractory Philadelphia Negative CD19+ Acute Lymphoblastic Leukemia // Blood. – 2021. – Т. 138. – С. 4404.

Weaver C. H. Blincyto Prolongs Survival in Acute Lymphoblastic Leukemia (ALL) //Studies. – 2021.